The Sachs Autumn Life Sciences Week incorporates the 11th Annual HealthTech Investment Forum and the 24th Annual Biotech in Europe Forum.

The 24th Annual Biotech in Europe Forum will take place on the 25th - 26th of September 2024 at the Mövenpick Hotel Basel. The event will be part of the Sachs Autumn Life Sciences Week, which will also incorporate the 11th Annual HealthTech Investment Forum (#Sachs_HTIF).

The physical programme will consist of the usual panels and keynotes, which will be available on-demand from the 2nd of October.  Additionally, there will be pre-arranged in-person meetings, live and on-demand company showcases and a reception. During the online week, virtual meetings will be available through the online meeting system.

Back for its 24th Annual Edition, this global bio-pharma industry event will address the main challenges in investment for 2024 as well as partnering and alliance management and prospects for 2025. Key players will contribute their insights in panels, which will cover the macro picture as well as innovation in different therapeutic sectors. This highly transactional event draws together an exciting cross-section of early-stage/pre-IPO, late-stage and public companies with leading investors, analysts, money managers and pharma licensing executives. Supported and designed by leading figures within Europe’s pharmaceutical and biotech industry, this event will once again be covered by our regular media partners.

lnvestors: complimentary passes
Other SECA members: 10% discount

Further information and registration here!